Comparison of the Value of Ultrasound-guided Fine Needle Aspiration Biopsy and Contrast-enhanced Ultrasound in Different Sizes of Thyroid Nodules

Overview

Journal Medicine (Baltimore)

Specialty General Medicine

Date 2024 Sep 27

PMID 39331869

Authors

Qi Liu

Liquan Ouyang

Shengchu Zhang

Yuxia Yang

Affiliations

Soon will be listed here.

Abstract

The purpose of this study was to evaluate the diagnostic value of ultrasound-guided fine needle aspiration biopsy (US-FNAB) and contrast-enhanced ultrasound (CEUS) in the presence of thyroid nodules of different sizes. We retrospectively analyzed 110 patients with surgically operated unimodular thyroid nodules in Yichang City Central Hospital from July 1, 2021, to April 1, 2023, all of whom underwent conventional thyroid ultrasound, CEUS, and US-FNAB, and all of whom were classified according to the size of nodules into <0.5, 0.5 to 1, and ≥1 cm groups. The diagnostic accuracy, sensitivity, and specificity of the 2 methods for benign and malignant nodules were calculated. Among 110 thyroid nodules, 102 were malignant nodules and 8 were benign nodules. In patients with nodule diameters <1 cm the sensitivity of US-FNAB and CEUS was 87.02% and 93.89%, respectively, and the specificity was 100.00% and 66.67%, with an accuracy of 87.31% and 93.28%, respectively. In patients with nodule diameter <0.5 cm, the sensitivities of US-FNAB and CEUS were 74.29% and 100.00%, respectively, and the differences were statistically significant (P < 0.05); in patients with nodule diameter 0.5 to 1 cm, the sensitivities of US-FNAB and CEUS were 79.59% and 95.92%, respectively, and the differences were statistically significant (P < 0.05); among patients with nodule diameters ≥1 cm, the sensitivities of US-FNAB and CEUS were 88.89% and 77.78%, respectively, with no statistically significant difference (P > 0.05). For thyroid nodules ≤1 cm in diameter, the sensitivity of CEUS examination was higher than that of US-FNAB; and CEUS still has good diagnostic accuracy in the diagnosis of benign and malignant thyroid nodules <0.5 cm, CEUS is recommended for thyroid nodules diagnosed negatively by US-FNAB with a diameter of <1 cm; and CEUS should be preferred for thyroid nodules with a diameter of <0.5 cm. CEUS should be preferred for thyroid nodules <0.5 cm in diameter.

References

Pedrazzini L, Baroli A, Marzoli L, Guglielmi R, Papini E . Cancer recurrence in papillary thyroid microcarcinoma: a multivariate analysis on 231 patients with a 12-year follow-up. Minerva Endocrinol. 2013; 38(3):269-79. View

Melany M, Chen S . Thyroid Cancer: Ultrasound Imaging and Fine-Needle Aspiration Biopsy. Endocrinol Metab Clin North Am. 2017; 46(3):691-711. DOI: 10.1016/j.ecl.2017.04.011. View

Xu Y, Xu L, Wang J . Clinical predictors of lymph node metastasis and survival rate in papillary thyroid microcarcinoma: analysis of 3607 patients at a single institution. J Surg Res. 2017; 221:128-134. DOI: 10.1016/j.jss.2017.08.007. View

Li F, Luo H . Comparative study of thyroid puncture biopsy guided by contrast-enhanced ultrasonography and conventional ultrasound. Exp Ther Med. 2013; 5(5):1381-1384. PMC: 3671767. DOI: 10.3892/etm.2013.1016. View

Qin J, Zhang S, Li G, Liu S, Shi X, Wu J . [Comparison of the diagnostic value of high frequency ultrasound and ultrasound-guided fine needle aspiration biopsy in papillary thyroid microcarcinoma]. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2021; 35(8):718-723. PMC: 10127802. DOI: 10.13201/j.issn.2096-7993.2021.08.010. View

Gao R, Jia X, Liang Y, Fan K, Wang X, Wang Y . Papillary Thyroid Micro Carcinoma: The Incidence of High-Risk Features and Its Prognostic Implications. Front Endocrinol (Lausanne). 2019; 10:74. PMC: 6384240. DOI: 10.3389/fendo.2019.00074. View

Facciorusso A, Mohan B, Crino S, Ofosu A, Ramai D, Lisotti A . Contrast-enhanced harmonic endoscopic ultrasound-guided fine-needle aspiration versus standard fine-needle aspiration in pancreatic masses: a meta-analysis. Expert Rev Gastroenterol Hepatol. 2021; 15(7):821-828. DOI: 10.1080/17474124.2021.1880893. View

Shawky M, Proctor I, Kurzawinski T, Abdel-Aziz T . Papillary thyroid microcarcinoma presenting as a metastasis to the brain. Ann R Coll Surg Engl. 2020; 102(5):e107-e110. PMC: 7374782. DOI: 10.1308/rcsann.2020.0041. View

Saade-Lemus S, Sridharan A, Smitthimedhin A, Bauer A, Cahill A, Darge K . Advanced Ultrasound Techniques for Differentiation of Benign Versus Malignant Thyroid Nodules: A Review. Ultrasound Q. 2021; 37(4):315-323. DOI: 10.1097/RUQ.0000000000000543. View

10.

Chen H, Liu W, Zhu H, Jiang D, Wang D, Chen Y . Diagnostic value of contrast-enhanced ultrasound in papillary thyroid microcarcinoma. Exp Ther Med. 2016; 11(5):1555-1562. PMC: 4840781. DOI: 10.3892/etm.2016.3094. View

11.

Yu D, Han Y, Chen T . Contrast-enhanced ultrasound for differentiation of benign and malignant thyroid lesions: meta-analysis. Otolaryngol Head Neck Surg. 2014; 151(6):909-15. DOI: 10.1177/0194599814555838. View

12.

Sung J, Na D, Kim K, Yoo H, Lee H, Kim J . Diagnostic accuracy of fine-needle aspiration versus core-needle biopsy for the diagnosis of thyroid malignancy in a clinical cohort. Eur Radiol. 2012; 22(7):1564-72. DOI: 10.1007/s00330-012-2405-6. View

13.

Liao L, Yi W, Wang Y, Yuan L . [Diagnostic value for the fine needle aspiration biopsy and contrast-enhanced ultrasound in thyroid imaging reported and data system Grade 4 nodules]. Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019; 44(9):1071-1077. DOI: 10.11817/j.issn.1672-7347.2019.190252. View

14.

Huang K, Bai Z, Bian D, Yang P, Li X, Liu Y . Diagnostic Accuracy of Contrast-Enhanced Ultrasonography in Papillary Thyroid Microcarcinoma Stratified by Size. Ultrasound Med Biol. 2019; 46(2):269-274. DOI: 10.1016/j.ultrasmedbio.2019.10.001. View

15.

Durante C, Grani G, Lamartina L, Filetti S, Mandel S, Cooper D . The Diagnosis and Management of Thyroid Nodules: A Review. JAMA. 2018; 319(9):914-924. DOI: 10.1001/jama.2018.0898. View

16.

Akgun G, Atlanoglu S, Korkmaz M, Ekici M, Gedik M . Diagnosis of Thyroid Micropapillary Carcinoma and Histopathological Changes after Fine-needle Aspiration Biopsy. J Coll Physicians Surg Pak. 2022; 32(4):445-450. DOI: 10.29271/jcpsp.2022.04.445. View

17.

Lombardi C, Bellantone R, De Crea C, Paladino N, Fadda G, Salvatori M . Papillary thyroid microcarcinoma: extrathyroidal extension, lymph node metastases, and risk factors for recurrence in a high prevalence of goiter area. World J Surg. 2010; 34(6):1214-21. DOI: 10.1007/s00268-009-0375-x. View

18.

Lim Y, Choi E, Yoon Y, Kim E, Koo B . Central lymph node metastases in unilateral papillary thyroid microcarcinoma. Br J Surg. 2009; 96(3):253-7. DOI: 10.1002/bjs.6484. View

19.

Ito Y, Miyauchi A, Kihara M, Fukushima M, Higashiyama T, Miya A . Overall Survival of Papillary Thyroid Carcinoma Patients: A Single-Institution Long-Term Follow-Up of 5897 Patients. World J Surg. 2018; 42(3):615-622. PMC: 5801380. DOI: 10.1007/s00268-018-4479-z. View

20.

Gharib H, Papini E, Garber J, Duick D, Harrell R, Hegedus L . AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ASSOCIAZIONE MEDICI ENDOCRINOLOGI MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR THE DIAGNOSIS AND MANAGEMENT OF THYROID NODULES--2016 UPDATE. Endocr Pract. 2016; 22(5):622-39. DOI: 10.4158/EP161208.GL. View